Sign in

Alzheimer disease trials, also abroad

902 open Alzheimer disease trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States364
China134
France85
Italy60
Canada58
Spain56
United Kingdom41
South Korea31
Germany28
Taiwan22
Japan21
Australia19
Czechia19
Netherlands18
Argentina17
Belgium17
Poland17
Brazil14
Bulgaria12
Greece12
Romania12
Slovakia11
Chile10
Sweden10
Croatia9
Israel9
Norway9
Puerto Rico9
Türkiye9
Switzerland8
Denmark8
Hong Kong8
Hungary8
Portugal8
Serbia8
India7
Austria6
Singapore5
Colombia4
Finland4
Ireland4
New Zealand4
Ukraine4
United Arab Emirates3
Peru2
Russia2
Cyprus1
Egypt1
Jordan1
Philippines1
Pakistan1
Réunion1
Saudi Arabia1
Thailand1
Vietnam1

The same trial often runs in several countries

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) has 7 sites in Mexico and runs in 31 countries. If a site near you is full, another one may still take people.

See Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) in all 31 countries
Alzheimer disease trials in Mexico – Frontlight Research